Іздеу

Шығарылым
Атауы
Авторлар
Kombinirovannaya terapiya bolevoy diabeticheskoy polineyropatii: rezul'taty pilotnogo issledovaniya
Khramilin V., Andreeva V., Demidova I.
SAKhARNYY DIABET: OT PONIMANIYa ETIOLOGII K VYBORU LEChENIYa
Kononenko I., Smirnova O.
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V., Nichitenko M., Chesnikova A.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.
REGIDRATATsIONNAYa TERAPIYa I VOZMOZhNOSTI EE KONTROLYa U PATsIENTOV S DIABETIChESKIMI KOMAMI (OBZOR LITERATURY)
Legun A., Vetsheva M.
Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti
Galstyan G.
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A., Baturova V., Pogromov A., Yu Baturova V.
DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?
Fomin V., Pulin A., Saginova E., Fomun V., Pulin A., Saginova E.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y., Biryukova E.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V., Chazova I., Fomin V.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY
Belyaeva E.
Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus
Mychka V., Zhernakova Y., Chazova I., Michka V., Jernakova Y., Chazova I.
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A., Mkrtumyan A.
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
Barsukov I., Demina A.
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
Ivanova M., Zhurtova I., Sizhazheva S., Gubachikova A.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T., Lomonova T.
Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity
Amosova M., Gurova O., Fadeev V.
Statins and the risk of diabetes: an evidence-based review
Leonova M.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
Features of urine microflora in diabetic patients
Chikanova A., Khamnuyeva L., Karnoukhova O., Sudakova N., Tokareva N.
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
Biryukova E.
Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment
Verbovoy A., Sharonova L.
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
Kurkin D., Volotova E., Bakulin D., Lomkina E., Tyurenkov I.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
GIPERGLIKEMIYa I OSTRYY KORONARNYY SINDROM
Martynov A., Akatova E., Nikolin O., Urlaeva I.
Opyt primeneniya Aktovegina v lechenii neyroishemicheskoy formy sindroma «diabeticheskaya stopa»
Dibirov M., Gadzhimuradov R., Khalidov O., Proshin A., Kakubava M.
Analiz effektivnosti i bezopasnosti primeneniya otechestvennogo insulina Rinsulin NPKh v gorode Nizhniy Novgorod
Zanozina O., Sorokina Y., Lovtsova L., Borovkov N.
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M., Koteshkova O.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N., Antsiferov M.
PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII
Gur'eva I., Svetlova O.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)
Demicheva T., Demicheva T.
INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT
Demidova I., Makova A., Demidova I., Makova A.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E., pl?midmagidsid Y.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.
Common bean (Phaseolus vulgaris L.)/
Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M., Antsiferov M.
LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa
Petunina N.
New directions of drugs Milgamma and Milgamma compositum use in the diabetes mellitus
Den'gin V., Dengin V.
Diabetic foot syndrome: approaches to treatment of infection
Privol'nev V., Privolnev V.
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M., Demidov N., Safronova T., Mishra O.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S., Apetova V.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
Is it possible to stop the diabetes epidemic?
Verbovoy A., Dolgikh Y., Verbovaya N.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.
Application of Cocarnit in complex treatment of patients with diabetic polyneuropathy in outpatient practice
Novikova L., Tarkhanova I., Dmitrieva O., Fomichev A., Kakaulina L.
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G., Antsiferov M., Alekseeva Y.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.
Therapy with nonsteroid antiinflammatory drugs in patients with acute nonspecific low back pain: dynamics of renal function: results of «PANDA» cogort study
Zolotovskaya I., Davydkin I., Borovkova N.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N., Antsiferov M., Dorofeeva L.
Metabolic syndrome and intestinal microbiota
Egshatyan L., Mkrtumyan A., Zvenigorodskaya L.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.
NEBIVOLOL V LEChENII ARTERIAL'NOY GIPERTENZII U BOL'NYKh VYSOKOGO RISKA
Minushkina L.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.
KLINIKA, DIAGNOSTIKA I LEChENIE DIABETIChESKOY NEYROPATII
Sharonova L., Verbovoy A., Sharonova D.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A., Tertychnaya E.
Metabolicheskiy sindrom u bol'nykh sakharnym diabetom i ego korrektsiya preparatami tioktovoy kisloty
Kurnikova I.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L., Sorokin M.
Rol' taurina i ego defitsita v organizme cheloveka i zhivotnykh
Antsiferov M.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A., Valitov B., Chernikova N., Antsiferov M.
HOW TO OVERCOME THE EFFECTS OF "HYPERGLYCEMIC" MEMORY?
Biryukova E., V Biryukova Y.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
ROLE OF GLYCATION END-PRODUCTS BLOCKERS IN THE DEVELOPMENT OF NEUROLOGIC COMPLICATIONS OF DIABETES MELLITUS
Podachina S., Podachina S.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I., Romantsova T., Glinkina I., Romantsova T.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M., Antsiferov M.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A., Mkrtumyan A.
Verification of the class of carbohydrate metabolism disorders in patients with hyperglycemia first detected on the background of acute coronary syndrome
Golitsyna T., Golitsina T.
Russian consensus on diabetes mellitus therapy in children and adolescents
Dedov I., Peterkova V., Kuraeva T., Dedov I., Peterkova V., Kuraeva T.
SOVREMENNYE PODKhODY K LEChENIYu SAKhARNOGO DIABETA TIPA 2 U MUZhChIN
Tishova Y., Kalinichenko S.
Disturbances of lipid metabolism in pregnancy
Tkacheva O., Galyautdinova A., Prokhorovich E., Mishina I., Torshkhoeva K., Tkacheva O., Galjautdinova A., Prochorovich E., Mishina I., Torshchoeva C.
Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes
Zilov A., Zilov A.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Novikova M., Demidov N.
What should the practitioner remember when managing patients with diabetic neuropathy
Isakova E., Kotov S.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.
Programmed labor for gestational diabetes mellitus - reserve for reducing the frequency of operative delivery
Grabovsky V., Kostin I., Tazhetdinov E.
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
Izhbuldina G., Novikova L.
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Demidov N., Mishra O., Antsiferov M.
POSSIBILITIES OF METHORMINE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: TEST OF TIME
Biryukova E., Solovyeva I., Platonova N.
Нәтижелер 343 - 101/200 << < 1 2 3 4 > >> 
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>